Stockreport

EXCLUSIVE: Alzamend Neuro Reveals Full Data From Nonclinical Study Of Its Lead Alzheimer's Drug Potential [Yahoo! Finance]

Alzamend Neuro, Inc.  (ALZN) 
PDF lithium exposures between AL001 and lithium carbonate in Alzheimer's transgenic mice. The study involved administering AL001 to 5XFAD mice, a recognized model for Alzh [Read more]